About
Technology
News
Contact

About
Technology
News
Contact

01

Oct

2018

Paul Little, Operating Partner in Lundbeckfonden Emerge, replaces Christian Elling as CEO of Insusense Therapeutics

News

Insusense Therapeutics website launches

4. January 2019

Lundbeck Foundation doubles its investment in Aarhus-based Insusense Therapeutics

20. October 2015

About Us

InsuSence Therapeutics is a product-focused biotechnology company based on novel breakthrough science in diabetes biology, which has the potential to quantum leap to important new Type 2 diabetes therapeutics.

News

Insusense Therapeutics website launches

4. January 2019

Lundbeck Foundation doubles its investment in Aarhus-based Insusense Therapeutics

20. October 2015

Contact

Insusense ApS
c/o Lundbeckfonden
Scherfigsvej 7
DK-2100 Copenhagen

Privacy Policy

Copyright © InsuSense Therapeutics, All Rights Reserved.